Birmingham City will not be taking another one of the SPFL’s top strikers as Hibs have held firm in their bid to keep Kevin Nisbet.

The striker arrived in the summer from Dunfermline for a six-figure sum of around £200k. He has hit the ground running too, Nisbet currently Hibs’ top scorer for the season, scoring 13 times in 29 matches. It’s form that has caught Birmingham City attention.

Birmingham City are after Nisbet.

Birmingham City are after Nisbet. (Photo by Mark Scates/SNS Group via Getty Images)

That’s on top of the combined 57 goals he scored for Raith Rovers and Dunfermline over the last two seasons as his career resurgence continues following his release from Partick Thistle a few terms ago.

Aitor Karanka’s side had initially tabled a deal of around £2 million for the striker but this was knocked back by Hibs, despite add ons and incentives meaning this fee would likely have risen. Then Birmingham City came back with an even bigger offer, despite spending £2million on Aberdeen’s Sam Cosgrove hours earlier.

£2.6million was put to Hibs and still Birmingham City have been unable to land Nisbet, Hibees chairman Ron Gordon sending out a message of ambition by knocking back an improved second Blues bid.

Birmingham City v Rotherham United - Sky Bet Championship

The Spaniard bid again. (Photo by James Williamson – AMA/Getty Images)

Hibs are not in a position where they need to sell and they have also rejected a seven-figure offer from Millwall for centre-back Ryan Porteous. Both Nisbet and the Scotland U21s star were on the bench amid the speculation on Saturday as Hibs beat Dundee United 2-0 at Tannadice.

It is thought that Birmingham City won’t come back in with a third bid for Nisbet as Hibs believe they can net a club-record fee for him come the end of the season, especially if he breaks into Steve Clarke’s squad for Euro 2020.

NTOF now offers a YouTube channel featuring exclusive interviews, post-match discussion, in-depth debate, and much more – LIKE and SUBSCRIBE and don’t miss any of our videos.

Have something to tell us about this article?